Evidence map›Paper›PMID 41049602›Full record

ArticleJAMIA open2025

Synthetic data for pharmacogenetics: enabling scalable and secure research.

Marko Miletic, Anna Bollinger, Samuel S Allemann, Murat Sariyar

Abstract read
In one paragraph

Article in JAMIA open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marko MileticInstitute for Optimisation and Data Analysis (IODA), Bern University of Applied Sciences, Biel, Switzerland.ORCID https://orcid.org/0009-0006-4208-6780
Anna BollingerDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-4616-2534
Samuel S AllemannDepartment of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.ORCID https://orcid.org/0000-0003-4067-9401
Murat SariyarInstitute for Optimisation and Data Analysis (IODA), Bern University of Applied Sciences, Biel, Switzerland.ORCID https://orcid.org/0000-0003-3432-2860

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study evaluates the performance of 7 synthetic data generation (SDG) methods-synthpop, avatar, copula, copulagan, ctgan, tvae, and the large language models-based tabula-for supporting pharmacogenetics (PGx) research. Materials and Methods: We used PGx profiles from 142 patients with adverse drug reactions or therapeutic failures, considering 2 scenarios: (1) a high-dimensional genotype dataset (104 variables) and (2) a phenotype dataset (24 variables). Models were assessed for (1) broad utility using propensity score mean squared error ( Results: Copula and synthpop consistently achieved strong performance across both datasets, combining low ε-identifiability (0.25-0.35) with competitive utility. Deep learning models like tabula and tvae trained for 10 000 epochs achieved lower Discussion: While deep learning models can achieve high distributional fidelity ( Conclusion: No single SDG method dominated across all criteria. For privacy-sensitive PGx applications, classical methods such as copula and synthpop offer a reliable trade-off between utility and privacy, making them preferable for high-dimensional, limited-sample settings.

Indexed as

artificial intelligence in healthcaredata privacygenomic datapharmacogeneticssynthetic data

Identifiers

PMID41049602
PMCPMC12492482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.